Highlights• The hormone therapy in transgender patients was not associated with an increased incidence of breast cancer• Risk measurement and therapeutic decision involving breast cancer and hormone therapy should be performed individually• Low rates of breast screening are observed in trans patients due to a lack of well-established guidelines• Mammography is indicated in breast cancer screening in the transgender population• It is necessary to make the medical environment more comfortable, respectful, and welcoming to transgender patients ©2024 Anjos et al.
No takes yet. Share an insight, caveat, or question.
Anjos et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: